<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Positive association between CD44 gene rs13347 cT polymorphism and risk of cancer in asians: a systemic review and meta-analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-06-13">13 June 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jinan</forename><surname>Shi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medical Oncology</orgName>
								<address>
									<addrLine>Zhejiang hospital</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yin</forename><surname>Duan</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Breast surgery</orgName>
								<orgName type="institution">Zhejiang Provincial Traditional chinese Medical hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lei</forename><surname>Pan</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Breast surgery</orgName>
								<orgName type="institution">Zhejiang Provincial Traditional chinese Medical hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoxi</forename><surname>Zhou</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of respiratory Medicine</orgName>
								<address>
									<addrLine>Zhejiang hospital, hangzhou, Zhejiang Province</addrLine>
									<country>People&apos;s republic of china</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tel</forename><surname>+86</surname></persName>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of respiratory Medicine</orgName>
								<address>
									<addrLine>Zhejiang hospital, 12 lingyin road, hangzhou 310009, Zhejiang Province</addrLine>
									<country>People&apos;s republic of china</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Positive association between CD44 gene rs13347 cT polymorphism and risk of cancer in asians: a systemic review and meta-analysis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-06-13">13 June 2016</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.2147/OTT.S104734</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:56+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>cancer</term>
					<term>CD44</term>
					<term>polymorphism</term>
					<term>meta-analysis</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: Cluster of differentiation 44 (CD44) is an important surface marker of cancer stem cells in a variety of tumors. A number of previous studies have been conducted to investigate the association between CD44 gene rs13347 CT polymorphism and cancer risk in humans; nevertheless, the results remain controversial. We therefore performed this meta-analysis to confirm the role of this polymorphism in susceptibility to human cancer. Materials and methods: The studies published up to December 2015 were searched in PubMed, Web of Science, and China National Knowledge Infrastructure databases. Twelve eligible case-control studies were identified, involving a total of 6,982 cases and 7,430 controls. Pooled odds ratio (OR) and corresponding 95% confidence interval (CI) were calculated using a fixed or random-effect model to estimate the strength of the association. Results: The results of the overall analyses indicated that CD44 gene rs13347 polymorphism was significantly associated with cancer risk in Asians (CT vs CC: OR =1.35, 95% CI =1.12-1.62; TT vs CC: OR =1.99, 95% CI =1.52-2.60; TT + CT vs CC: OR =1.41, 95% CI =1.16-1.71; and TT vs CC + CT: OR =1.74, 95% CI =1.41-2.14), especially in Chinese population (CT vs CC: OR =1.42, 95% CI =1.16-1.75; TT vs CC: OR =2.13, 95% CI =1.58-2.86; TT + CT vs CC: OR =1.50, 95% CI =1.21-1.87; and TT vs CC + CT: OR =1.80, 95% CI =1.43-2.26). In stratified analyses by cancer types, there was evidence for an association between this polymorphism and nasopharyngeal cancer and breast cancer, respectively. Conclusion: The results of this meta-analysis suggest that the CD44 gene rs13347 CT polymorphism is associated with elevated risk of human cancer in Asians, especially in Chinese population. Further well-designed studies on a larger population covering other ethnicities should be carried out to validate our results.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>Cancer is currently a serious public health burden in the world, which results from interactions between accumulations of genetic mutation and environmental risk factors. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> In recent years, a small subgroup of cancer cells, called cancer stem cells (CSCs), have been proved to be responsible for tumor initiation, progression, metastasis, recurrence, and drug resistance and cause cancer heterogeneity. <ref type="bibr" target="#b2">3</ref> Thus, eliminating CSCs is considered to be efficient and critical in cancer therapy. <ref type="bibr" target="#b3">4</ref> Several cell surface markers have been found to identify CSCs, and overexpression of these markers, such as cluster of differentiation 44 (CD44), CD24, CD133, CD166, and ALDH1A1, indicates severe clinical features and poor prognosis in a number of cancers. <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> Among these cell surface markers, CD44 is one of the most frequently reported markers, which was utilized to isolate CSCs from other cancer cells. <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> CD44, a transmembrane glycoprotein, is ubiquitously expressed in many cell types. <ref type="bibr" target="#b13">14</ref> As a cell surface receptor for hyaluronate and osteopontin, CD44 is involved in many biological and physiological processes including cell migration, hematopoiesis, lymphocyte homing, embryonal development, and apoptosis. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> Besides its regulation of cellular processes, CD44 plays a critical role in tumor cell proliferation, differentiation, invasion, and migration, which contributes to the progression and metastasis of tumors. <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref> Therefore, overexpression of CD44 leads to the development of tumors and poor prognosis of several human malignancies. <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> In addition, it has been reported that CD44 + cancer cells represent enhanced resistance to chemotherapy in the nude mice-engrafted tumor model. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref> Recent studies have revealed that the genetic variants of CD44 gene could influence tumor cell growth and migration, <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref> which were associated with the risk prediction and prognosis of various human cancers. <ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref> The gene encoding CD44 is located on chromosome 11p13. <ref type="bibr" target="#b29">30</ref> A growing number of studies have been carried out to investigate the effects of several CD44 gene single nucleotide polymorphisms (SNPs) on cancer risk. Among them, the rs13347 CT polymorphism, located on the 3′-untranslated region (3′-UTR) of CD44 gene, is the most frequently studied. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32</ref> This SNP might influence the CD44 gene expression, since it has been reported that subjects carrying TT and CT genotypes had remarkably higher levels of CD44 protein than those carrying CC genotype in breast cancer, nasopharyngeal carcinoma, and acute myeloid leukemia. <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b32">33</ref> To date, a number of case-control studies have been conducted to evaluate the role of CD44 gene rs13347 polymorphism in predisposition to several human cancers. <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref> Nevertheless, the results from different articles remain controversial. To clarify the association between CD44 gene rs13347 polymorphism and risk of cancer, we performed this metaanalysis by integrating data from eligible published studies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods search strategy</head><p>Relevant reports were retrieved by searching the electronic databases: PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI; from inception to December 20, 2015), using the following keywords: ("CD44") and ("tumor" or "cancer" or "carcinoma" or "neoplasm" or "malignancy") and ("polymorphism" or "polymorphisms" or "SNP" or "variant" or "variation"). The search was filtered to English-language journals in PubMed. Besides, we also performed a manual search among the references of the relevant publications and related articles. The studies with overlapping data by the same investigators or based on the same population were checked prudently, and the most recent articles covering the largest numbers of cases and controls would be included.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>inclusion and exclusion criteria</head><p>The eligible studies in this meta-analysis were required to strictly follow the predetermined criteria: 1) use a casecontrol study design, 2) evaluate the association between CD44 rs13347 CT polymorphism and risk of cancer, and 3) report an estimation of odds ratio (OR) and 95% confidence interval (CI), or sufficient data to allow calculation of these two statistics. The main exclusion criteria were studies 1) that did not use a case-control design (eg, case reports, letters, animal studies, reviews, and editorials), 2) that are duplicate of previous publications, 3) that involve inherited cancers, 4) with sample size of cases or controls 100, and 5) in which genotype distribution of controls is not in agreement with the Hardy-Weinberg equilibrium.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data extraction</head><p>All the eligible studies were reviewed by two authors independently to extract useful data. The following information were collected: the name of the first author, the year of publication, the ethnicity of study population, the country of origin, sample size of cases and controls, source of controls (hospital based or population based), genotyping method, and genotype distributions of cases and controls. The disagreements in this step were solved by rechecking the original data to reach a consensus.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>statistical analysis</head><p>Hardy-Weinberg equilibrium was estimated by the goodnessof-fit test based on the chi-square test in the control group of each study. <ref type="bibr" target="#b35">36</ref> Pooled analysis was conducted to estimate the strength of the association between CD44 rs13347 CT polymorphism and cancer risk, using an OR with a corresponding 95% CI. The pooled ORs were calculated by comparisons with a codominant model (CT vs CC and TT vs CC), a dominant model (TT + CT vs CC), and a recessive model (TT vs CC + CT). The values of the pooled ORs were tested by the Z-test. <ref type="bibr" target="#b36">37</ref> Stratified analyses were further performed based on country (People's Republic of China or India), specific cancer types (nasopharyngeal cancer, gallbladder cancer, or breast cancer), source of controls (hospital based or population based), and genotyping method (TaqMan or matrix-assisted laser desorption/ionization time-of-flight). Heterogeneity among the included studies was evaluated by the chi-square-based Q-test. <ref type="bibr" target="#b37">38</ref> Pooled ORs were calculated using a fixed (Mantel-Haenszel method <ref type="bibr" target="#b38">39</ref> ) or a random (DerSimonian-Laird method 40 ) effective model, according to the absence (P0.10 and I 2 50%) or presence (P0.10 or I 2 50%) of heterogeneity. Sensitivity analyses were performed by omitting one study each time to evaluate the stability of the results. The potential publication bias of the included studies was assessed by Begg's funnel plots graphically and Egger's test quantitatively. <ref type="bibr" target="#b40">41</ref> All the statistical calculations were carried out with Stata/ SE software Version 12.0 (StataCorp LP, College Station, TX, USA), using two-sided P-values, and P0.05 was considered to be significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>literature search and characteristics of eligible studies</head><p>A total of 890 potential relevant records were retrieved through the search strategy described previously. Eight hundred and seventy records were excluded after title or abstract scanning. After full-text reviewing, eight studies were excluded. Finally, 12 studies were eligible for pooled analysis. The flow process of detailed literature search and study selection is shown in <ref type="figure" target="#fig_0">Figure 1</ref>.</p><p>There were 12 case-control studies included in this metaanalysis, <ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref> involving a total of 6,982 cases and 7,430 controls. All the studies were conducted on an Asian population. Among them, nine originated from the People's Republic of China and the other three from India. There was no study conducted on Caucasians or Africans. Cancer types included bladder cancer, non-small-cell lung cancer, gallbladder cancer, colorectal cancer, nasopharyngeal cancer, hepatocellular carcinoma, oral cancer, breast cancer, and acute myeloid leukemia. The distribution of genotypes in all the control groups was in agreement with Hardy-Weinberg equilibrium. The characteristics of each eligible study are listed in <ref type="table" target="#tab_0">Table 1</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative synthesis</head><p>The pooled results of the present meta-analysis are shown in <ref type="table">Table 2</ref> and <ref type="figure" target="#fig_2">Figure 2</ref>. There was an association between CD44 gene rs13347 polymorphism and risk of cancer in the overall analyses. Significantly elevated cancer risk was revealed in the codominant genetic model (CT vs CC: OR =1.35, 95% CI =1.12-1.62 and TT vs CC: OR =1.99, 95% CI =1.52-2.60), dominant model (TT + CT vs CC: OR =1.41, 95% CI =1.16-1.71), and recessive model (TT vs CC + CT: OR =1.74, 95% CI =1. <ref type="bibr">41-2.14)</ref>. In the subgroup analyses stratified by country, there was evidence in Chinese population for an association between this SNP and cancer risk (CT vs CC: OR =1.42, 95% CI =1.16-1.75; TT vs CC: OR =2.13, 95% CI =1.58-2.86; TT + CT vs CC: OR =1.50, 95% CI =1.21-1.87; and TT vs CC + CT: OR =1.80, 95% CI =1. <ref type="bibr">43-2.26)</ref>. According to the source of control, both population based and hospital based subgroups were linked to cancer risk. For specific cancer types, increased risk among studies of nasopharyngeal cancer and breast cancer was observed in several genetic models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Test for heterogeneity and sensitivity analysis</head><p>There was significant heterogeneity in the overall comparisons under all the genetic models (CT vs CC: P0.001 and I 2 =82.4% for heterogeneity, TT vs CC: P0.001 and I 2 =67.7% for heterogeneity, TT + CT vs CC: P0.001 and I 2 =85.8% for heterogeneity, and TT vs CC + CT: P=0.031 and I 2 =48.3% for heterogeneity; <ref type="table">Table 2</ref>). The source of heterogeneity was investigated by covariates, such as country, cancer type, source of control, and genotype method. According to subgroup analyses, country and cancer type might be the source of heterogeneity. To explore the main origin of heterogeneity, a meta-regression analysis was performed in the comparison TT vs CC, which indicated that cancer type contributed to the most proportion in heterogeneity. Moreover, two studies on nasopharyngeal cancer <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b41">42</ref> were under suspicion. After omitting these two studies, the pooled OR was not altered (TT vs CC: OR =1.74, 95% CI =1.39-2.16), whereas the heterogeneity remarkably decreased (TT vs CC: P=0.110 and I 2 =34.7% for heterogeneity).</p><p>Sensitivity analysis was performed, and the pooled ORs were not influenced qualitatively in all the genetic models by removing any single study, which indicated that the pooled results of this meta-analysis were statistically stable <ref type="figure" target="#fig_3">(Figure 3</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publication bias</head><p>The potential publication bias of the eligible studies was assessed by Begg's funnel plots graphically and Egger's test statistically. The shapes of funnel plots in all the genetic models did not indicate any evidence of an obvious asymmetry <ref type="figure" target="#fig_4">(Figure 4)</ref>. Meanwhile, Egger's test revealed that there was no publication bias either (CT vs CC: P=0.139, TT vs CC: P=0.755, TT + CT vs CC: P=0.186, and TT vs CC + CT: P=0.975). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Cancer is a group of heterogeneous diseases that result from genetic and environmental factors, as well as their interactions. According to CSC theory, CSCs can drive cancer initiation, progression, and metastasis. <ref type="bibr" target="#b2">3</ref> As an important CSC surface maker in variant tumors, CD44 is reportedly a risk factor and poor prognostic molecular marker in various cancers. <ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref> CD44 plays a crucial role in the invasion and migration of cancer cells. In addition, overexpression of CD44 in primary tumors has been revealed to be associated with early metastasis in several human cancers. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b50">51</ref> CD44 gene rs13347 CT polymorphism is a common genetic variation in the 3′-UTR. It has been proved that the expression of CD44 was modulated by mRNAs, and rs13347 CT polymorphism could alter has-mir-509-3p-mediated CD44 gene expression activity. Recently, a number of studies have been carried out to evaluate the association between this SNP and risk of cancer; however, the results were conflicting. The possible reason may be that the effects of CD44 on the development of different cancer types are not the same.</p><p>To our knowledge, the present meta-analysis, including 6,982 cases and 7,430 controls from 12 case-control studies, is the first comprehensive study to assess the association between CD44 gene rs13347 polymorphism and risk of cancer. We found an association between CD44 gene rs13347 polymorphism and human cancer risk by pooling all the data from eligible studies. The results were robust because the pooled ORs did not alter statistically in sensitivity analyses. Stratified analyses suggested that this association was mainly in a Chinese population. According to specific cancer types, this polymorphism was linked to elevated risk of gallbladder cancer, nasopharyngeal cancer, and breast cancer, the significance of which was limited because there were only two studies for each cancer type. Since there was significant heterogeneity by the Q-test in all the genetic models, a meta-regression analysis was performed to explore the origin of heterogeneity. As a result, different cancer types were considered to be the main source of interstudy variance, especially two studies on nasopharyngeal cancer. By removing these two studies, the heterogeneity significantly decreased but pooled ORs were not altered. However, this kind of heterogeneity was hard to eliminate in the present meta-analysis, because there were only one or two studies for one specific cancer type. Moreover, pooling data from different cancer types might affect the significance of this meta-analysis because different cancer types might give rise to different host responses, <ref type="table">Table 2</ref> Pooled analysis of association between cD44 rs13347 cT polymorphism and cancer risk in asians  Abbreviations: PB, population based; HB, hospital based; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight; OR, odds ratio; CI, confidence interval.  and the interactions between different environmental factors and host might also influence the susceptibility to different cancer types. Some limitations of the present meta-analysis should be pointed out. First, the pooled results were calculated based on unadjusted estimates, which limited us to perform a more precise assessment on adjusted estimates by several important factors such as sex, age, lifestyle, etc. Thus, lack of the baseline information restricted further evaluation of the potential interactions, because malignancy predisposition might be influenced by gene-gene and gene-environment interactions. Second, most of the included studies just focused on the relationship between CD44 gene rs13347 polymorphism and cancer risk, which made it hard to assess the effects of CD44 gene haplotypes composed of different CD44 gene SNPs on carcinogenesis. There was evidence that CD44 gene rs187115 AG and rs115214213 TC polymorphisms were associated with cancer risk. <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b43">44</ref> Thus, the status of other CD44 gene polymorphisms might cover up the effects of rs13347 TC polymorphism, which could lead to controversial results among different studies.</p><p>Despite these limitations, advantages in this meta-analysis should also be acknowledged. First, the statistical power was remarkably increased since we pooled a substantial number of cases and controls. Second, the quality of all the eligible studies met the inclusion criteria completely and strictly. Third, there was no publication bias observed through Begg's funnel plots and Egger's test, which indicated that the pooled outcomes should be unbiased.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>The results of the present meta-analysis were robust and credible. The relationship between CD44 gene rs13347 polymorphism and cancer risk was assessed, and this SNP was associated with elevated cancer risk in Asians. To draw a more conclusive result, further studies should be conducted with more detailed information on individuals and environmental factors, concerning the effects of different haplotypes and other SNPs and enrolling properly identified cases and well-matched controls, especially in other ethnicities including Africans and Caucasians, to validate the role of CD44 gene rs13347 CT polymorphism in carcinogenesis. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OncoTargets and Therapy</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publish your work in this journal</head><p>Submit your manuscript here: http://www.dovepress.com/oncotargets-and-therapy-journal OncoTargets and Therapy is an international, peer-reviewed, open access journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.</p><p>OncoTargets and Therapy 2016:9</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc>Flow diagram of the study identification process.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2</head><label>2</label><figDesc>Forest plot of the association between CD44 gene rs13347 cT polymorphism and risk of cancer in the overall analysis (TT vs cc). Note: Weights are from random effects analysis. Abbreviations: OR, odds ratio; CI, confidence interval.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3</head><label>3</label><figDesc>sensitivity analysis of the association between CD44 gene rs13347 cT polymorphism and risk of cancer in the overall analysis (TT vs cc). Abbreviation: CI, confidence interval.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4</head><label>4</label><figDesc>Begg's funnel plot of publication bias test in the overall analysis (TT vs cc); each point represents a single study for the indicated association. Abbreviations: logOr, natural logarithm of the Or; se of logOr, standard error of the logOr; Or, odds ratio.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>characteristics of eligible studies in the meta-analysis</figDesc><table><row><cell cols="3">ID Reference Year Country</cell><cell>Source of</cell><cell>Cancer type</cell><cell>Genotyping</cell><cell>Sample size</cell><cell cols="3">Genotype (case/control)</cell><cell>HWE</cell></row><row><cell></cell><cell></cell><cell></cell><cell>control</cell><cell></cell><cell>method</cell><cell>case/control</cell><cell>CC</cell><cell>CT</cell><cell>TT</cell></row><row><cell>1</cell><cell>Weng</cell><cell>2015 People's republic</cell><cell>hB</cell><cell>Bladder</cell><cell>TaqMan</cell><cell>275/275</cell><cell>138/143</cell><cell cols="2">111/117 26/15</cell><cell>0.153</cell></row><row><cell></cell><cell>et al 44</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>2</cell><cell>liu</cell><cell>2015 People's republic</cell><cell>PB</cell><cell>nsclc</cell><cell>TaqMan</cell><cell>234/468</cell><cell>179/337</cell><cell cols="2">51/121 4/10</cell><cell>0.823</cell></row><row><cell></cell><cell>et al 32</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>3</cell><cell>Yadav</cell><cell>2016 india</cell><cell>PB</cell><cell>gallbladder</cell><cell>TaqMan</cell><cell>610/250</cell><cell>378/162</cell><cell cols="2">201/80 31/8</cell><cell>0.620</cell></row><row><cell></cell><cell>et al 46</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>Wu</cell><cell>2015 People's republic</cell><cell>hB</cell><cell>colorectal</cell><cell cols="2">MalDi-TOF 946/989</cell><cell>416/578</cell><cell cols="2">441/348 89/63</cell><cell>0.279</cell></row><row><cell></cell><cell>et al 45</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>5</cell><cell>lou</cell><cell>2014 People's republic</cell><cell>hB</cell><cell cols="2">nasopharyngeal TaqMan</cell><cell>272/489</cell><cell>104/288</cell><cell cols="2">126/174 42/27</cell><cell>0.915</cell></row><row><cell></cell><cell>et al 42</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>6</cell><cell>chou</cell><cell>2014 People's republic</cell><cell>hB</cell><cell cols="2">hepatocellular TaqMan</cell><cell>203/561</cell><cell>110/295</cell><cell cols="2">72/223 21/43</cell><cell>0.924</cell></row><row><cell></cell><cell>et al 34</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>7</cell><cell>chou</cell><cell>2014 People's republic</cell><cell>hB</cell><cell>Oral</cell><cell>TaqMan</cell><cell>599/561</cell><cell>287/295</cell><cell cols="2">262/223 50/43</cell><cell>0.924</cell></row><row><cell></cell><cell>et al 35</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>8</cell><cell>sharma</cell><cell>2014 india</cell><cell>na</cell><cell>gallbladder</cell><cell>TaqMan</cell><cell>405/200</cell><cell>293/154</cell><cell cols="2">104/42 8/4</cell><cell>0.572</cell></row><row><cell></cell><cell>et al 43</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>9</cell><cell>Wu</cell><cell>2015 People's republic</cell><cell>PB</cell><cell>aMl</cell><cell cols="2">MalDi-TOF 421/461</cell><cell>163/254</cell><cell cols="2">196/171 62/36</cell><cell>0.340</cell></row><row><cell></cell><cell>et al 31</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">10 Tulsyan</cell><cell>2013 india</cell><cell>hB</cell><cell>Breast</cell><cell>TaqMan</cell><cell>258/241</cell><cell>191/178</cell><cell>60/57</cell><cell>7/6</cell><cell>0.577</cell></row><row><cell></cell><cell>et al 29</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">11 Xiao</cell><cell>2013 People's republic</cell><cell>PB</cell><cell cols="3">nasopharyngeal MalDi-TOF 906/943</cell><cell>386/606</cell><cell cols="3">418/297 102/40 0.637</cell></row><row><cell></cell><cell>et al 33</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">12 Jiang</cell><cell>2013 People's republic</cell><cell>PB</cell><cell>Breast</cell><cell cols="2">MalDi-TOF 1,853/1,992</cell><cell cols="4">812/1,146 850/727 190/119 0.795</cell></row><row><cell></cell><cell>et al 28</cell><cell>of china</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note>Abbreviations: PB, population based; hB, hospital based; na, not available; hWe, hardy-Weinberg equilibrium; aMl, acute myeloid leukemia; nsclc, non-small-cell lung cancer; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight.</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">submit your manuscript | www.dovepress.com Dovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">OncoTargets and Therapy 2016:9 submit your manuscript | www.dovepress.comDovepress Dovepress</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgment</head><p>This work was granted by National Natural Science Foundation of China (grant no 91229104).</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure</head><p>The authors report no conflicts of interest in this work.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Genome maintenance mechanisms for preventing cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><forename type="middle">H</forename><surname>Hoeijmakers</surname></persName>
		</author>
		<idno type="DOI">10.1038/35077232</idno>
		<idno type="PMID">11357144</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">411</biblScope>
			<biblScope unit="issue">6835</biblScope>
			<biblScope unit="page" from="366" to="374" />
			<date type="published" when="2001-05" />
			<publisher>Springer Nature America, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cancer: More of polygenic disease and less of multiple mutations? A quantitative viewpoint</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anders</forename><surname>Bredberg</surname></persName>
		</author>
		<idno type="DOI">10.1002/cncr.25440</idno>
		<idno type="PMID">20862743</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<title level="j" type="abbrev">Cancer</title>
		<idno type="ISSN">0008-543X</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="440" to="445" />
			<date type="published" when="2010-09-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Cancer stem cells: an evolving concept</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Long</forename><forename type="middle">V</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Vanner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Dirks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Connie</forename><forename type="middle">J</forename><surname>Eaves</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc3184</idno>
		<idno type="PMID">22237392</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Cancer</title>
		<title level="j" type="abbrev">Nat Rev Cancer</title>
		<idno type="ISSN">1474-175X</idno>
		<idno type="ISSNe">1474-1768</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="133" to="143" />
			<date type="published" when="2012-01-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Understanding the cancer stem cell</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bomken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Fišer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Heidenreich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vormoor</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjc.6605821</idno>
		<idno type="PMID">20664590</idno>
		<idno type="PMCID">PMC2939794</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/6605821.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSN">0007-0920</idno>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="439" to="445" />
			<date type="published" when="2010-07-27" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kefeng</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaonan</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yunhong</forename><surname>Zhan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiguo</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xuefeng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xia</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bin</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12032-013-0574-z</idno>
		<idno type="PMID">23585015</idno>
		<idno type="ark">ark:/67375/VQC-RJGKFMFG-M</idno>
		<idno type="istexId">C417E6D4CF280E7E222302B558ABC6A6FC1370CC</idno>
	</analytic>
	<monogr>
		<title level="j">Medical Oncology</title>
		<title level="j" type="abbrev">Med Oncol</title>
		<idno type="ISSN">1357-0560</idno>
		<idno type="ISSNe">1559-131X</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">574</biblScope>
			<date type="published" when="2013-04-13" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shuji</forename><surname>Mikami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryuichi</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeo</forename><surname>Kosaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideyuki</forename><surname>Saya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mototsugu</forename><surname>Oya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasunori</forename><surname>Okada</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.29137</idno>
		<idno type="PMID">25123505</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1504" to="1514" />
			<date type="published" when="2014-09-17" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Abstract 499: High-level expression of the stem-cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyungeun</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyojin</forename><surname>Ihm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Y</forename><surname>Ro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sunghee</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Munjung</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong</forename><forename type="middle">Mee</forename><surname>Cho</surname></persName>
		</author>
		<idno type="DOI">10.1158/1538-7445.am2011-499</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Res</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">8 Supplement</biblScope>
			<biblScope unit="page" from="499" to="499" />
			<date type="published" when="2011-04-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">CD24 overexpression in cancer development and progression: a meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1149" to="1156" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Prognostic role of CD133 expression in colorectal cancer: a meta-analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ke</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jianjun</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Junshu</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2407-12-573</idno>
		<idno type="PMID">23216926</idno>
		<idno type="PMCID">PMC3532409</idno>
		<ptr type="open-access" target="https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-12-573" />
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<title level="j" type="abbrev">BMC Cancer</title>
		<idno type="ISSNe">1471-2407</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">573</biblScope>
			<date type="published" when="2012-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chao</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhigang</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaotao</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yang</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dihong</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ping</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0070958</idno>
		<idno type="PMID">23940674</idno>
		<idno type="PMCID">PMC3733726</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e70958</biblScope>
			<date type="published" when="2013-08-05" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Isolation and Characterization of Multipotent Human Keloid-Derived Mesenchymal-Like Stem Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jai-Hee</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Sik</forename><surname>Kwak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gyuman</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hye-Youn</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byung</forename><forename type="middle">Sun</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaeyeo</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kyung</forename><forename type="middle">Su</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seung-Cheol</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Isaac</forename><surname>Maeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bona</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun</forename><forename type="middle">Kyung</forename><surname>Jun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soonseong</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aeree</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sejong</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyunggee</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ki</forename><forename type="middle">Dong</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seungkwon</forename><surname>You</surname></persName>
		</author>
		<idno type="DOI">10.1089/scd.2007.0210</idno>
		<idno type="PMID">18710345</idno>
		<ptr type="open-access" target="https://www.liebertpub.com/doi/pdf/10.1089/scd.2007.0210" />
	</analytic>
	<monogr>
		<title level="j">Stem Cells and Development</title>
		<title level="j" type="abbrev">Stem Cells and Development</title>
		<idno type="ISSN">1547-3287</idno>
		<idno type="ISSNe">1557-8534</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="713" to="724" />
			<date type="published" when="2008-08" />
			<publisher>Mary Ann Liebert Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Isolation and characterization of multipotent mesenchymal stem cells in nasal polyps</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Sun</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joo-Hoo</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ju-Hyung</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Eun</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Il-Ho</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heung-Man</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1177/1535370214553898</idno>
		<idno type="PMID">25294891</idno>
		<idno type="PMCID">PMC4935324</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4935324?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Experimental Biology and Medicine</title>
		<title level="j" type="abbrev">Exp Biol Med (Maywood)</title>
		<idno type="ISSN">1535-3702</idno>
		<idno type="ISSNe">1535-3699</idno>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="185" to="193" />
			<date type="published" when="2014-10-06" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Prospective identification of tumorigenic breast cancer cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Al-Hajj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Wicha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Benito-Hernandez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">F</forename><surname>Clarke</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0530291100</idno>
		<idno type="PMID">12629218</idno>
		<idno type="PMCID">PMC153034</idno>
		<ptr type="open-access" target="https://www.pnas.org/content/pnas/100/7/3983.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3983" to="3988" />
			<date type="published" when="2003-03-10" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">CD44 cell adhesion molecules</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Goodison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Urquidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Tarin</surname></persName>
		</author>
		<idno type="DOI">10.1136/mp.52.4.189</idno>
		<idno type="PMID">10694938</idno>
		<idno type="PMCID">PMC395698</idno>
		<idno type="ark">ark:/67375/NVC-WTXL3M34-F</idno>
		<idno type="istexId">1F2150B083AF4A033ECBB59A292B21A6783C2284</idno>
		<ptr type="open-access" target="https://mp.bmj.com/content/molpath/52/4/189.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pathology</title>
		<title level="j" type="abbrev">Molecular Pathology</title>
		<idno type="ISSN">1366-8714</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="189" to="196" />
			<date type="published" when="1999-08-01" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">CD44: From adhesion molecules to signalling regulators</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helmut</forename><surname>Ponta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><surname>Sherman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">A</forename><surname>Herrlich</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrm1004</idno>
		<idno type="PMID">12511867</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Molecular Cell Biology</title>
		<title level="j" type="abbrev">Nat Rev Mol Cell Biol</title>
		<idno type="ISSN">1471-0072</idno>
		<idno type="ISSNe">1471-0080</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="45" />
			<date type="published" when="2003-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zoller</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc3023</idno>
		<idno type="PMID">21390059</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Cancer</title>
		<title level="j" type="abbrev">Nat Rev Cancer</title>
		<idno type="ISSN">1474-175X</idno>
		<idno type="ISSNe">1474-1768</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="254" to="267" />
			<date type="published" when="2011-03-10" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Marhaba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zöller</surname></persName>
		</author>
		<idno type="DOI">10.1023/b:hijo.0000032354.94213.69</idno>
		<idno type="PMID">15339042</idno>
		<idno type="ark">ark:/67375/VQC-2KF0Z001-4</idno>
		<idno type="istexId">F129B44291D1B54F098BDCBEFCD3CAA7778196B2</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Histology</title>
		<title level="j" type="abbrev">Histochem J</title>
		<idno type="ISSN">1567-2379</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="231" />
			<date type="published" when="2003-03" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The emerging role of CD44 in regulating skeletal micrometastasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ashleigh</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suzanne</forename><surname>Mcfarlane</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">G</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">J J</forename><surname>Waugh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2005.05.006</idno>
		<idno type="PMID">15979783</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Letters</title>
		<title level="j" type="abbrev">Cancer Letters</title>
		<idno type="ISSN">0304-3835</idno>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2006-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lishanthi</forename><surname>Udabage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">R</forename><surname>Brownlee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">K</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tracey</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yexcr.2005.07.026</idno>
		<idno type="PMID">16125700</idno>
	</analytic>
	<monogr>
		<title level="j">Experimental Cell Research</title>
		<title level="j" type="abbrev">Experimental Cell Research</title>
		<idno type="ISSN">0014-4827</idno>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="205" to="217" />
			<date type="published" when="2005-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Prognostic value of CD44 expression in nonsmall cell lung cancer: a systematic review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Lv</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Exp Pathol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3632" to="3646" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rhonda</forename><forename type="middle">L</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lauren</forename><forename type="middle">M</forename><surname>Reinke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marin</forename><forename type="middle">S</forename><surname>Damerow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denise</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lewis</forename><forename type="middle">A</forename><surname>Chodosh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chonghui</forename><surname>Cheng</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci44540</idno>
		<idno type="PMID">21393860</idno>
		<idno type="PMCID">PMC3049398</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/44540/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1064" to="1074" />
			<date type="published" when="2011-03-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Prognostic significance of CD44 variant 2 upregulation in colorectal cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ozawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ichikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y-W</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Oshima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Miyata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Nakazawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-B</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shiozawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Akaike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ota</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kunisaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Taniguchi</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2014.253</idno>
		<idno type="PMID">24921913</idno>
		<idno type="PMCID">PMC4102936</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/bjc2014253.pdf" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSN">0007-0920</idno>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="365" to="374" />
			<date type="published" when="2014-06-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">CD44 and EpCAM: Cancer-Initiating Cell Markers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rachid</forename><surname>Marhaba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pamela</forename><surname>Klingbeil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tobias</forename><surname>Nuebel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Irina</forename><surname>Nazarenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Markus</forename><surname>Buechler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Margot</forename><surname>Zoeller</surname></persName>
		</author>
		<idno type="DOI">10.2174/156652408786733667</idno>
		<idno type="PMID">19075676</idno>
	</analytic>
	<monogr>
		<title level="j">Current Molecular Medicine</title>
		<title level="j" type="abbrev">CMM</title>
		<idno type="ISSN">1566-5240</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="784" to="804" />
			<date type="published" when="2008-12-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and Chemoresistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steven</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lilly</forename><forename type="middle">Y W</forename><surname>Bourguignon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajpath.2010.11.077</idno>
		<idno type="PMID">21356346</idno>
		<idno type="PMCID">PMC3069910</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Pathology</title>
		<title level="j" type="abbrev">The American Journal of Pathology</title>
		<idno type="ISSN">0002-9440</idno>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="956" to="963" />
			<date type="published" when="2011-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">CD44 Plays a Functional Role in Helicobacter pylori-induced Epithelial Cell Proliferation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nina</forename><surname>Bertaux-Skeirik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rui</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Schumacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maxime</forename><forename type="middle">M</forename><surname>Mahe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amy</forename><forename type="middle">C</forename><surname>Engevik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jose</forename><forename type="middle">E</forename><surname>Javier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">M</forename><surname>Peek Jr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karen</forename><surname>Ottemann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Veronique</forename><surname>Orian-Rousseau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gregory</forename><forename type="middle">P</forename><surname>Boivin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Helmrath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yana</forename><surname>Zavros</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.ppat.1004663</idno>
		<idno type="PMID">25658601</idno>
		<idno type="PMCID">PMC4450086</idno>
		<ptr type="open-access" target="https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1004663&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLOS Pathogens</title>
		<title level="j" type="abbrev">PLoS Pathog</title>
		<idno type="ISSNe">1553-7374</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e1004663</biblScope>
			<date type="published" when="2015-02-06" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cong</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Xia</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wen-Bin</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hong-Ya</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi-Yuan</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lei</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1111/jop.12296</idno>
		<idno type="PMID">25482572</idno>
		<idno type="ark">ark:/67375/WNG-J6LS66B1-G</idno>
		<idno type="istexId">155419740389EF79E404E038F5F2E92D027B6EEF</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Oral Pathology &amp; Medicine</title>
		<title level="j" type="abbrev">J Oral Pathol Med</title>
		<idno type="ISSN">0904-2512</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="353" to="360" />
			<date type="published" when="2014-12-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Prognostic significance of CD44s expression in resected non-small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoon</forename><forename type="middle">Ho</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hye</forename><forename type="middle">Sung</forename><surname>Won</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun</forename><forename type="middle">Kyoung</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sook</forename><forename type="middle">Hee</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sang</forename><forename type="middle">Young</forename><surname>Roh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young</forename><forename type="middle">Seon</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Ho</forename><surname>Byun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chan-Kwon</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin</forename><forename type="middle">Hyoung</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2407-11-340</idno>
		<idno type="PMID">21819617</idno>
		<idno type="PMCID">PMC3164633</idno>
		<ptr type="open-access" target="https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-11-340" />
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<title level="j" type="abbrev">BMC Cancer</title>
		<idno type="ISSNe">1471-2407</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">340</biblScope>
			<date type="published" when="2011-08-07" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">CD44 rs13347 C&gt;T polymorphism predicts breast cancer risk and prognosis in Chinese populations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lan</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieqiong</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xun</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yonghe</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Na</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongchun</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiachun</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yifeng</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1186/bcr3225</idno>
		<idno type="PMID">22788972</idno>
		<idno type="PMCID">PMC3680922</idno>
		<ptr type="open-access" target="https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3225" />
	</analytic>
	<monogr>
		<title level="j">Breast Cancer Research</title>
		<title level="j" type="abbrev">Breast Cancer Res</title>
		<idno type="ISSNe">1465-542X</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">105</biblScope>
			<date type="published" when="2012-07-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">CD44 Gene Polymorphisms in Breast Cancer Risk and Prognosis: A Study in North Indian Population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sonam</forename><surname>Tulsyan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gaurav</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Punita</forename><surname>Lal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sushma</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rama</forename><forename type="middle">Devi</forename><surname>Mittal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Balraj</forename><surname>Mittal</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0071073</idno>
		<idno type="PMID">23940692</idno>
		<idno type="PMCID">PMC3733640</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e71073</biblScope>
			<date type="published" when="2013-08-05" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">N</forename><surname>Goodfellow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Banting</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">V</forename><surname>Wiles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><surname>Tunnacliffe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohamed</forename><surname>Parkar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ellen</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosemarie</forename><surname>Dalchau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">W</forename><surname>Fabre</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.1830120807</idno>
		<idno type="PMID">7140811</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Immunology</title>
		<title level="j" type="abbrev">Eur. J. Immunol.</title>
		<idno type="ISSN">0014-2980</idno>
		<idno type="ISSNe">1521-4141</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="659" to="663" />
			<date type="published" when="1982" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Functional polymorphisms in theCD44gene and acute myeloid leukemia cancer risk in a Chinese population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongchun</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieqiong</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yonghe</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Na</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Depei</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yifeng</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1002/mc.22078</idno>
		<idno type="PMID">24038513</idno>
		<idno type="ark">ark:/67375/WNG-2FDHNQKX-7</idno>
		<idno type="istexId">138521CD5EAE202527D961C6D7C64134B1BB7041</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Carcinogenesis</title>
		<title level="j" type="abbrev">Mol. Carcinog.</title>
		<idno type="ISSN">0899-1987</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="102" to="110" />
			<date type="published" when="2013-09-04" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yaosheng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haifeng</forename><surname>Qing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiuyun</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cheng</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhou</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shubin</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.12659/msm.894357</idno>
		<idno type="PMID">26356590</idno>
		<idno type="PMCID">PMC4573070</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4573070?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Medical Science Monitor</title>
		<title level="j" type="abbrev">Med Sci Monit</title>
		<idno type="ISSNe">1643-3750</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2694" to="2700" />
			<date type="published" when="2015" />
			<publisher>International Scientific Information, Inc.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mang</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sunhong</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huifen</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiujun</forename><surname>Cai</surname></persName>
		</author>
		<idno type="DOI">10.1093/mutage/get035</idno>
		<idno type="PMID">23883608</idno>
		<ptr type="open-access" target="https://academic.oup.com/mutage/article-pdf/28/5/577/12915457/get035.pdf" />
	</analytic>
	<monogr>
		<title level="j">Mutagenesis</title>
		<idno type="ISSN">0267-8357</idno>
		<idno type="ISSNe">1464-3804</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="577" to="582" />
			<date type="published" when="2013-07-24" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying-Erh</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming-Ju</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hui-Ling</forename><surname>Chiou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hsiang-Lin</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shun-Fa</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tzy-Yen</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1155/2014/231474</idno>
		<idno type="PMID">24971320</idno>
		<idno type="PMCID">PMC4058263</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/bmri/2014/231474.pdf" />
	</analytic>
	<monogr>
		<title level="j">BioMed Research International</title>
		<title level="j" type="abbrev">BioMed Research International</title>
		<idno type="ISSN">2314-6133</idno>
		<idno type="ISSNe">2314-6141</idno>
		<imprint>
			<biblScope unit="volume">2014</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2014" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying-Erh</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming-Ju</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chung-Han</forename><surname>Hsin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Whei-Ling</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi-Cheng</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu-Hsien</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shu-Ching</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shun-Fa</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chiao-Wen</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0093692</idno>
		<idno type="PMID">24699672</idno>
		<idno type="PMCID">PMC3974805</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093692&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e93692</biblScope>
			<date type="published" when="2014-04-03" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Exact Significance Levels of Goodness-of-Fit Tests for the Hardy-Weinberg Equilibrium</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Haber</surname></persName>
		</author>
		<idno type="DOI">10.1159/000153199</idno>
		<idno type="PMID">7262889</idno>
	</analytic>
	<monogr>
		<title level="j">Human Heredity</title>
		<title level="j" type="abbrev">Hum Hered</title>
		<idno type="ISSN">0001-5652</idno>
		<idno type="ISSNe">1423-0062</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="161" to="166" />
			<date type="published" when="1981" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Statistical methods in cancer research. Volume II -the design and analysis of cohort studies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">E</forename><surname>Breslow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">E</forename><surname>Day</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IARC Sci Publ</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1" to="406" />
			<date type="published" when="1987" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Measuring inconsistency in meta-analyses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.327.7414.557</idno>
		<idno type="PMID">12958120</idno>
		<idno type="PMCID">PMC192859</idno>
		<idno type="ark">ark:/67375/NVC-QJDCZCKZ-4</idno>
		<idno type="istexId">643263D3B945EA135ECBEE4BD099C0C6AB6BD09F</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc192859?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<title level="j" type="abbrev">BMJ</title>
		<idno type="ISSN">0959-8138</idno>
		<idno type="ISSNe">1468-5833</idno>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="issue">7414</biblScope>
			<biblScope unit="page" from="557" to="560" />
			<date type="published" when="2003-09-06" />
			<publisher>BMJ</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Statistical aspects of the analysis of data from retrospective studies of disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Mantel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Haenszel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="719" to="748" />
			<date type="published" when="1959" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Meta-analysis in clinical trials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><surname>Dersimonian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nan</forename><surname>Laird</surname></persName>
		</author>
		<idno type="DOI">10.1016/0197-2456(86)90046-2</idno>
		<idno type="PMID">3802833</idno>
		<idno type="PII">0197-2456(86)90046-2</idno>
		<idno type="ark">ark:/67375/6H6-NQ8X10JN-L</idno>
		<idno type="istexId">57F64D8AA486BA31E66347792B6CA3AC99E9ED32</idno>
	</analytic>
	<monogr>
		<title level="j">Controlled Clinical Trials</title>
		<title level="j" type="abbrev">Controlled Clinical Trials</title>
		<idno type="ISSN">0197-2456</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="177" to="188" />
			<date type="published" when="1986-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Publication and related bias in metaanalysis: power of statistical tests and prevalence in the literature</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Sterne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gavaghan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Egger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1119" to="1129" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Two polymorphisms of CD44 3′UTR weaken the binding of miRNAs and associate with nasopharyngeal carcinoma in a Chinese population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">N</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">B</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2444" to="2452" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiran</forename><forename type="middle">Lata</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anu</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annapurna</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sonam</forename><surname>Tulsayan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vijay</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanjeev</forename><surname>Misra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ashok</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Balraj</forename><surname>Mittal</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-013-1340-8</idno>
		<idno type="PMID">24186075</idno>
	</analytic>
	<monogr>
		<title level="j">Tumor Biology</title>
		<title level="j" type="abbrev">Tumor Biol.</title>
		<idno type="ISSN">1010-4283</idno>
		<idno type="ISSNe">1423-0380</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="2583" to="2589" />
			<date type="published" when="2013-11-05" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei-Chun</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu-Hui</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shun-Fa</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shian-Shiang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wu-Hsien</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chao-Wen</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ching-Hsuan</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying-Erh</forename><surname>Chou</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-015-4566-9</idno>
		<idno type="PMID">26662954</idno>
	</analytic>
	<monogr>
		<title level="j">Tumor Biology</title>
		<title level="j" type="abbrev">Tumor Biol.</title>
		<idno type="ISSN">1010-4283</idno>
		<idno type="ISSNe">1423-0380</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="6971" to="6977" />
			<date type="published" when="2015-12-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Min</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hong-Guo</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bo-An</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hong-Feng</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi-Ming</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei-Ding</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0127557</idno>
		<idno type="PMID">26010608</idno>
		<idno type="PMCID">PMC4444206</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0127557&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLOS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e0127557</biblScope>
			<date type="published" when="2015-05-26" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anu</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annapurna</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neeraj</forename><surname>Rastogi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sushma</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ashok</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vijay</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Balraj</forename><surname>Mittal</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-015-3929-6</idno>
		<idno type="PMID">26318430</idno>
	</analytic>
	<monogr>
		<title level="j">Tumor Biology</title>
		<title level="j" type="abbrev">Tumor Biol.</title>
		<idno type="ISSN">1010-4283</idno>
		<idno type="ISSNe">1423-0380</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1835" to="1844" />
			<date type="published" when="2015-08-30" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Expression of stem cell marker CD44 in prostate cancer biopsies predicts cancer grade in radical prostatectomy specimens</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Konstanty</forename><surname>Korski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><surname>Malicka-Durczak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><surname>Bręborowicz</surname></persName>
		</author>
		<idno type="DOI">10.5114/pjp.2014.48190</idno>
		<ptr type="open-access" target="https://www.termedia.pl/Journal/-55/pdf-24351-10?filename=expression.pdf" />
	</analytic>
	<monogr>
		<title level="j">Polish Journal of Pathology</title>
		<title level="j" type="abbrev">pjp</title>
		<idno type="ISSN">1233-9687</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="291" to="295" />
			<date type="published" when="2014" />
			<publisher>Termedia Sp. z.o.o.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Feifeng</forename><surname>Jing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hun</forename><forename type="middle">Jin</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chang</forename><forename type="middle">Hyun</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Young</forename><forename type="middle">Jin</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jae</forename><forename type="middle">Hyuk</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyeong</forename><forename type="middle">Rok</forename><surname>Kim</surname></persName>
		</author>
		<idno type="DOI">10.3892/ijo.2015.2844</idno>
		<idno type="PMID">25625240</idno>
		<ptr type="open-access" target="http://www.spandidos-publications.com/10.3892/ijo.2015.2844/download" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Oncology</title>
		<idno type="ISSN">1019-6439</idno>
		<idno type="ISSNe">1791-2423</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1582" to="1588" />
			<date type="published" when="2015-01-23" />
			<publisher>Spandidos Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Cancer stem cell markers CD44, CD133 in primary gastric adenocarcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nosrati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Naghshvar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Khanari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Cell Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="279" to="286" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huimin</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mingzi</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Song</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danye</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yingying</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Song</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juanjuan</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bei</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms16023391</idno>
		<idno type="PMID">25658794</idno>
		<idno type="PMCID">PMC4346902</idno>
		<ptr type="open-access" target="https://www.mdpi.com/1422-0067/16/2/3391/pdf" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<title level="j" type="abbrev">IJMS</title>
		<idno type="ISSNe">1422-0067</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="3391" to="3404" />
			<date type="published" when="2015-02-04" />
			<publisher>MDPI AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Long-term survival after surgical treatment of metachronous bilateral adrenal metastases of non-small cell lung carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Taira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kawabata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ichi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Case Rep</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="444" to="446" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
